Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Zydus Medtech and Braile Biomedica of Brazil announce global licensing pact to commercialise TAVI technology".
Press Release Apr 17 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Apr 16 2025
- Press Release Apr 11 2025
- Press Release Mar 18 2025
- Press Release Mar 16 2025
- Press Release Mar 14 2025
Later from Zydus Lifesciences
- ITC Reversal Of Common ITC U/s17(2) Required In Relation To Activity Of Subscription And Redemption Of Mutual Funds
- Press Release Apr 25 2025
- Press Release Apr 26 2025
- Press Release Apr 30 2025
- Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences